Top 10 des publications de l’équipe
- Routy, B et al., Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91-97 (2017)
- L. Zitvogel et al., Nutrition, inflammation and cancer. Nat Immunol 18, 843-850 (2017)
- C. Lopez-Otin, L. Galluzzi, J. M. Freije, F. Madeo, G. Kroemer, Metabolic Control of Longevity. Cell 166, 802-821 (2016).
- F. Pietrocola et al., Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer Cell 30, 147-160 (2016).
- L. Zitvogel, M. Ayyoub, B. Routy, G. Kroemer, Microbiome and Anticancer Immunosurveillance. Cell 165, 276-287 (2016).
- L. Galluzzi, A. Buque, O. Kepp, L. Zitvogel, G. Kroemer, Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer Cell 28, 690-714 (2015).
- M. Vetizou et al., Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science350, 1079-1084 (2015).
- E. Vacchelli et al., Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Science350, 972-978 (2015).
- G. Kroemer, L. Senovilla, L. Galluzzi, F. Andre, L. Zitvogel, Natural and therapy-induced immunosurveillance in breast cancer. Nat Med 21, 1128-1138 (2015).
- M. Gentili et al., Transmission of innate immune signaling by packaging of cGAMP in viral particles. Science 349, 1232-1236 (2015).
Catégorie de la page:
